Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment
Journal for ImmunoTherapy of Cancer · 2026-01 · 14 (1) · e013697
DOI: 10.1136/jitc-2025-013697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 22.01.2026. Verfasst von Juanjuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, CD8-Positive T-Lymphocytes, Chemokine CXCL9, Chemokine CXCL10. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nankai University Tianjin Application, State Key Laboratory of Medicinal Chemical Biology and the Fundamental Research Funds for the Central University, Nankai university, NSFC.
Abstract (Originalsprache)
Background
Elevated levels of SPP1 + tumor-associated macrophages (TAMs) are associated with reduced CD8 + T cell infiltration and poorer prognosis in cancer patients, but direct evidence demonstrating a causal role for SPP1 + TAMs in excluding CD8 + T cells is still missing. The precise mechanisms by which SPP1-activated signaling pathways and macrophage-derived factors regulate CD8 + T cell trafficking remain poorly understood.
Methods
We established multiple tumor mouse models to study the function of macrophage SPP1 in the tumor environment, especially its role in the relationship between macrophages and CD8 T cells. We combined the single-cell (sc) RNA sequencing data of clinical tumor samples and tumor tissues from Spp1 fl/fl-Lyz2-Cre mice to identify the differences in SPP1-related genes and found that SPP1 could regulate the expression of CXCL9 and CXCL10 in macrophages. Through Western blotting, immunofluorescence staining, and flow cytometry analyses, we elucidated the mechanistic basis by which macrophage-specific SPP1 deficiency suppressed tumorigenesis.
Results
This study demonstrated that macrophage-derived SPP1 played a crucial role in suppressing CD8 T cell infiltration, promoting tumor progression, and diminishing the effectiveness of immune checkpoint inhibitor (ICI) therapy. Sc-RNA sequencing analysis revealed a marked increase in CD8 T cell populations within tumor tissues of Spp1 fl/fl-Lyz2-Cre mice. Furthermore, a negative correlation was observed between CD8 T cells and SPP1 macrophages in human colorectal cancer specimens. Genetic deletion of SPP1 in macrophages markedly enhanced tumor growth suppression in a manner dependent on CD8 T cell-mediated immunity. Mechanistically, SPP1 deficiency in macrophages led to elevated mitochondrial reactive oxygen species (ROS) production, resulting in the accumulation of cytosolic double-stranded DNA (dsDNA) fragments. This accumulated dsDNA activated the cGAS-STING pathway, leading to subsequent STAT1 phosphorylation. The enhanced STAT1 activity upregulated the expression of chemokines CXCL9 and CXCL10, thereby facilitating CD8 T cell recruitment into the tumor microenvironment.
Conclusions
Deletion of SPP1 in TAMs upregulates CXCL9/10 production by activating the ROS-DNA fragment/cGAS-STING/STAT1 pathway, thereby enhancing CD8 T cell infiltration, inhibiting tumor progression, and improving ICI treatment outcomes in tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Nankai University, Tianjin, China.
- School of Statistics and Data Science, LPMC and KLMDASR, Nankai University, Tianjin, China.
- Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China ryang@nankai.edu.cn xc198129@163.com.
- Department of Immunology, Nankai University, Tianjin, China ryang@nankai.edu.cn xc198129@163.com.
- Translational Medicine Institute, Tianjin Union Medical Center of Nankai University, Tianjin, China.
- State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Förderung
- Nankai University Tianjin Application
- State Key Laboratory of Medicinal Chemical Biology and the Fundamental Research Funds for the Central University, Nankai university
- NSFC
- A Ministry of Science and Technology
- Tianjin Science and Technology Commission
Zitieren
APA
Wang, J., Shi, Y., Gao, Y., Zhu, N., Liu, Y., Zhang, Y., Xu, C., & Yang, R. (2026). Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment. Journal for ImmunoTherapy of Cancer, 14(1), e013697. https://doi.org/10.1136/jitc-2025-013697
Vancouver
Wang J, Shi Y, Gao Y, Zhu N, Liu Y, Zhang Y, et al. Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment. Journal for ImmunoTherapy of Cancer. 2026;14(1):e013697. doi:10.1136/jitc-2025-013697
BibTeX
@article{Wang2026,
author = {Wang, Juanjuan and Shi, Yi and Gao, Yunhuan and Zhu, Ningning and Liu, Yuqing and Zhang, Yuan and Xu, Chen and Yang, Rongcun},
title = {Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {1},
pages = {e013697},
doi = {10.1136/jitc-2025-013697}
}
EUVIMED